Title : Immunosuppression for pancreatic islet transplantation.

Pub. Date : 2004 Mar

PMID : 15041369






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The development by the Edmonton group of a sirolimus-based, steroid-free, low-tacrolimus regimen was a significant breakthrough that allowed the rate of insulin independence after islet transplantation to increase from 13% to 80% at 1 year. Tacrolimus insulin Homo sapiens
2 Drawbacks include the side effects of sirolimus and the reduction in insulin independence to 50% at 3 years, the latter being attributed to prolonged tacrolimus exposure. Tacrolimus insulin Homo sapiens